Abstract
Latin Americans (LA) are a heterogeneous, multiethnic group of individuals who inhabit the continental countries in Latin America (LATAM), Caribbean islands and constitute the largest ethnic minority in the USA. Commonly used terminology and ethno racial classifications to define these groups may not be accurate. Risk for multiple sclerosis (MS) among LA is generally low to medium but frequencies are increasing in the American hemisphere. Genome-Wide Association Studies (GWAS) in LA show diverse variants and genetic proportions among Mestizos, the most representative ethnic population, who themselves are the product of centuries of interracial mixing between Native Americans (or Amerindians), White Caucasian Europeans, and Black Africans. Genetic distribution diversity appears to be related to migratory and historical and socio-political factors in LATAM. Epidemiologic studies show an extremely low prevalence of MS among non-mixed Amerindians; this has been attributed to protective ancestral Asian genetics and possibly, environmental factors. Mestizos and biracial LA of African ancestry have more susceptibility to MS apparently due to the historical introduction of the European HLA-DRB1*1501 gene. Contribution from HLA typing, GWAS, and ancestry informative markers (AIMs) has been determinant in the current LA genetic understanding but more regional studies are needed. The relationship between genetics and disease regional distribution is emphasized.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Tullman MJ. Overview of the epidemiology, diagnosis and disease progression associated with multiple sclerosis. Am J Manag Care. 2013;19(2 Suppl):S15–20.
Kingwell E, Marriott JJ, Jette N, et al. Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol. 2013;13:128. doi:10.1186/1471-2377-13-128.
Dilokhornsakull P, Valuck RJ, Nair KV, et al. Multiple sclerosis prevalence in the United States commercially insured population. Neurology. 2016;86(11):1014–21.
Abad EP, Pérez M, Alarcón T, et al. Epidemiological evidence of multiple sclerosis in Ecuador. Mult Scler. 2008; 14: S55 (suppl)
Arambide G, de la Maza M, Perez-Zuno JA, et al. The prevalence of multiple sclerosis in the city of San Pedro GG. Mex Arq Neuropsiquiatr. 2004;62:11.
Cristiano E, Rojas JI, Romano M, et al. The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review. Mult Scler J. 2013;19:844–54.
Rivera VM. Multiple sclerosis in Latin America. Neuroepidemiology. 2009;32:293–5.
National Multiple Sclerosis Society. www.nationalmssociety.org. 2017. Accessed 1 Apr 2017.
Wagner LB, Archer NP, Williamson DM, et al. Updated prevalence estimates of multiple sclerosis in Texas 1998–2003. Texas Med 2009; 105 (2): 105 (6). https://dshs.texas.gov/epitox/reports/update_mstx98_03.pdf. Accessed 1 Apr 2017.
Rivera VM, Landero S. Multiple sclerosis in Mexican population. Int J MS Care. 2005/2006; 7: 143–47.
Rodriguez J. Latinos who have MS in the US. Mercury News April 16, 2007. www.mercurynews.com/2807/04/16/disabling-ailment-gives-patients-pause-and-a-cause/. Accessed 2 April 2017.
Ballerini C, Guerini FR, Rombola G, et al. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol. 2004;150:178–85.
Weinshenker B, Rodriguez M. Epidemiology of multiple sclerosis. In: Gorelick PB, Alter M, editors. Handbook of neuroepidemiology. New York: Marcel Decker Inc; 1994. p. 533–67.
Alcina A, Abad-Grau Mdel M, Fedetz M, et al. Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different populations. PLoS One. 2012;7(1):e29819. doi:10.1371/journal:pone.00298. (2013, accessed 1 April 2017
The International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genome wide study. N Engl J Med. 2007;357:1–13.
Rivera VM. The terms Latino and Anglo and tendency to early Alzheimer’s disease. Arch Neurol. 2005;62(11):1787.
United States Census Bureau. 1980 Overview. 2017. https://www.Census.Gov/History/. Accessed 1 Apr 2017.
2010 Census Shows America Diversity. 2010. https://www.census.gov/newsroom/releases/archives/18...census/. Accessed 1 Apr 2017.
Hispanic Heritage Month 2015. https://www.census.gov/topics/population.html. 2015. Accessed 1 April 2917.
Population distribution by race/ethnicity. www.kkf.org/other/state-indicator/distribution-by-racethnicity/ (2017, accessed 1 April 2017).
Hodges G. First Americans. National Geographic January 2015; 127–137.
Burgeon L, Burke A, Highman T. Earliest human presence in North American dated to the last Glacial Maximum: new radiocarbon from bluefish caves, Canada PLoS One January 6, 2017. doi: 10.137/journalpone.0169486
• Tokunaga K, Ohashi J, Bannai M, et al. Genetic link between Asians and Native Americans: evidence from HLA genes and haplotypes. Human Immmunol. 2001;62(9):1001–9. Tokunaga et al studied polymorphisms of HLA class I and II genes in East Asians and correspondence analysis with Ainu and Native American populations. These groups shared numerous alleles and haplotypes suggesting they are descendants from ancestral East Asian peoples
Alvarez-Iglesias V, Jaime JC, Carracedo A, et al. Coding region mitochondrial DNA SNPs: targeting East Asian and Native American haplotypes. Forensic Science International: Genetics. 2007;1:44–55.
Schurr TG. Mitochondrial DNA and the peopling of the new world. Am Sci 2000; 1–10.
Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001;22:117–39.
• Corona T, Rodríguez JL, Otero E, et al. Multiple sclerosis in Mexico. Hospital cases at the National Institute of Neurology and Neurosurgery, Mexico City. Neurología. 1996;11:170–3. Corona et al produced this seminal retrospective study spanning for 10 years in central Mexico. Their review did not identify any MS case among the five main Amerindian populations in the region
Velázquez M, López P, Rivera C, et al. Características epidemiológicas de la esclerosis múltiple en un estado fronterizo con los Estados Unidos de Norteamérica. Arch Neurocien (Mex). 2002;7(3):147–50.
De la Maza FM, Arambide GG. Prevalencia de la esclerosis múltiple en el municipio de San Pedro Garza García. Nuevo Léon Avances-Medicina Interna. 2006;3(9):7–10.
•• Flores J, González S, Morales X, et al. Absence of multiple sclerosis and demyelinating diseases among Lacandonians, a Pure Amerindian Ethnic Group in Mexico. Multiple Sclerosis International 2012, Article ID 292631, 4 pages, doi: 10.1155/2012/292631. Flores et al carried this on-site epidemiological study in a non-mixed Amerindian group in the Chiapas jungle, using a protocol specifically designed to confirm the absence of MS and other demyelinating diseases in native populations .
Sánchez JL, Aguirre C, Arcos-Burgos OM, et al. Prevalence of multiple sclerosis in Colombia. Rev Neurol. 2000;31(12):1101–3.
Rivera VM, Cabrera JA. La Esclerosis Múltiple en Latinoamérica. Señales de un aumento en la incidencia. Médico Interamericano. 2000;19(10):458–65.
Gracia F, Castillo LC, Benzadón A, et al. Prevalence and incidence of multiple sclerosis in Panama (2000-2005). Neuroepidemiology. 2009;32:287–93.
Abad P, Pérez M, Castro FC, et al. Prevalencia de Esclerosis Múltiple en Ecuador. Neurologia. 2010;25(5):309–13.
The 2nd LACTRIMS (Latin American Committee for Treatment and Research in Multiple Sclerosis) Congress. Monterrey, Mexico, 8-12, October 2002. Rev Neurol 2002; 35 (12): 1175–1197.
Mirsattari SM, Johnston JB, McKenna R, et al. Aboriginals with multiple sclerosis. HLA types and predominance of neuritis optica. Neurology. 2001;56:317–23.
Svenson LW, Warren S, Narran KG, et al. Prevalence of multiple sclerosis in First Nations people in Alberta. Canada Neurol Sci. 2007;34(2):175–80.
Saeed J, Rieckmann P, Yee I, et al. Characteristics of multiple sclerosis in aboriginals living in British Columbia. Mult Scler J. 2012;18(9):1239–43.
Wallin MT, Culpepper WJ, Coffman P, et al. The Gulf War era multiple sclerosis cohorts: age and incidence rates by race, sex and service. Brain. 2012;135(Pt 6):1778–85.
Aboriginal Peoples Survey (ARS). www.statcan.gc.ca2017 (2017, accessed 2 April 2017).
Lambrecht KN. Aboriginal consultation, environmental assessment, and regulatory review in Canada. Saskatchewan University of Regina Press. 2013;31
ICMNStaff. Census: Mexicans, 4th largest tribe. Indian Country Media Network. https://indiancountrymedianetwork.com/history/genealogy/4th-largest-tribe-in-us-mexicans-who-call-themselves-american-indian/ August 5, 2013 (2013, accessed 2 April 2017).
Papais-Alvarenga RM, Vasconcelos CC, Carra A, et al. Central nervous system idiopathic inflammatory demyelinating disorders in South America: a descriptive, multicenter, cross-sectional study. PLoS One. 2015;10:e0127757.
Wang S, Ray N, Rojas SW, et al. Geographic patterns of genome admixture in Latin American Mestizos. PLoS/Genetics 2008 doi: 10.1371/journal.pgen.10.1000037 (2008, accessed 2 April 2017).
Martinez-Fierro ML, Beuten J, Leach RJ, et al. Ancestry informative markers and mixture proportions in northeastern Mexico. J Hum Genet. 2009;54(9):504–9.
Silva-Zolezzi I, Hidalgo-Miranda A, Estrada-Gil J, et al. Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico. PNAS. 2009;106(21):8611–6.
Seguin B, Hardy B-J, Singer PA, et al. Genomics public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN). Nat Rev Genet. 2008;9:56–9.
Alvarado-de la Barrera C, Zúñiga-Ramos J, Ruiz-Morales J, et al. HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis. Neurology. 2000;55:287–1900.
•• Ordoñez G, Romero S, Orozco L, et al. Genomewide admixture study in Mexican Mestizos with multiple sclerosis. Clin Neurol Neurosurg. 2015;130:55–60. Ordoñez et al studied Mexican Mestizos with MS and healthy controls genotyped with several instruments including ancestry determination. Enriched European ancestry provided susceptibility while Indigenous ancestry of Asian origin seemed to confer protection
Rojas OL, Rojas-Villarraga A, Cruz-Tapias P, et al. HLA class II polymorphisms in Latin American patients with multiple sclerosis. Autoimmun Rev. 2010;9:407–13.
Patrucco L, Larriba J, Redal MA, et al. HLA-DRB1 and multiple sclerosis in Argentina. Eur J Neurol. 2009;16:427–9.
Brum DG, Barreira AA, Louzada-Junior P, et al. Association of the HLA-DRB1*15 allele group and the DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil. J Neuroimmunol. 2007;189:118–24.
Stepler R, Brown A. Statistical portrait of Hispanics in the United States. Pew Research Center APNL 19, 2016. www.pewhispanic.org (2016, accessed 3 April 2017).
Langer-Gould A, Brara SM, Beaver BE, et al. Incidence of multiple sclerosis in multiple racial and ethnic groups. Neurology. 2013;80(18):1734–9.
Isobe N, Gourrand P-A, Harbo HF, et al. Genetic risk variants in African Americans with multiple sclerosis. Neurology. 2013;8(13):219–27.
Cree BA, Reich DE, Khan O, et al. Modification of multiple sclerosis phenotypes by African ancestry at HLA. Arch Neurol. 2009;66(2):226–33.
• Alves-Leon SV, Papais-Alvarenga R, Magalhâes M, et al. Ethnicity-dependent association of HLA-DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients. Acta Neurol Scand. 2007;115(5):306–11. Alves- Leon et al performed Polymerase Chain Reaction (PCR) and PCR-sequence-specific primer amplification techniques in MS Brazilians and healthy controls finding significant HLA haplotype differences among patients of African and European descent while the allele HLA DQB1*0602 conferred susceptibility regardless of ethnicity .
Werneck LC, Lorenzoni PJ, Arndt RC, et al. The immunogenetics of multiple sclerosis. The frequency of HLA-alleles class 1 and 2 is lower in southern Brazilians than in European populations. Arq Neuropsiquiatr. 2016;74(8):607–16.
Instituto Brazileiro de Geografia e Estatistica (IBGE) www.ibge.gov.br (2010, accessed 3 Apeil 2017).
Cabre P, Heinslef O, Merle U, et al. Multiple sclerosis and neuromyelitis óptica in Martinique (French West Indies). Neurology. 2001;56(4):507–14.
Quelvennec E, Bera O, Cabre P. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome. Tissue Antigens. 2003;61(12):166–71.
Instituto Nacional de Estadística y Geografía (Mexico). Panorama Sociodemográfico de México. https://www.inegl.org.mx (2015, accessed 3 April 2017).
Toro J, Cuellar-Giraldo D, Diaz-Cruz C, et al. HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population. Neurol Neuroimmunol Neuroinflamm. 2016;3:e192. doi:10.1212/NXI.0000000000000192.
Correale J, Faez M. Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol. 2007;61:97–108.
Infante E, Olivo A, Alaez C, et al. Molecular analysis of HLA class I alleles in the Mexican Seri Indians: implications of their origin. Tissue Antigens. 1999;54(1):35–42.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Victor M. Rivera declares no potential conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Demyelinating Disorders
Rights and permissions
About this article
Cite this article
Rivera, V.M. Multiple Sclerosis in Latin Americans: Genetic Aspects. Curr Neurol Neurosci Rep 17, 57 (2017). https://doi.org/10.1007/s11910-017-0768-4
Published:
DOI: https://doi.org/10.1007/s11910-017-0768-4